Dionex (DNEX) Tops Q2 View By 6c
More News related to DNEX
- Dionex (DNEX) President, CEO Resigns
- Dionex Announces Resignation of Chief Executive Officer
- Dionex Enters Into Agreement With Caliper Life Sciences to Acquire Product Line for Water Sample Preparation
- Dionex (DNEX) Tops Q1 View By 9c; Guides; Increases Buyback By 1M Shares
- Dionex (DNEX) Tops Q2 View By 6c
More News related to Earnings
- Sterne Agee Downgrades World Acceptance Corp. (WRLD) to Neutral
- B. Riley Downgrades Trustmark (TRMK) to Sell
- B. Riley Downgrades Big 5 Sporting Goods (BGFV) to Neutral
- Sterne Agee Downgrades Suntrust Bank (STI) to Neutral
- Lazard Downgrades Allergan (AGN) to Hold
Dionex (Nasdaq: DNEX) reports Q2 EPS of $0.76, 6 cents better than the analyst estimate of $0.70. Revenues for the quarter were $98.7 million, versus the consensus of $95.45 million.
Related Categories
EarningsStocks Mentioned
-0.63Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
